- Price caps imposed by the Indian National Pharmaceutical Pricing Authority prompts Abbott (ABT +0.2%) to file to remove its Absorb and Alpine stents from the market. Medtronic (MDT +1.1%) has done the same regarding its Resolute Onyx.
- The Indian regulator has also set limits on trade margins, discounts and other promotions used to sell higher-end products.
Abbott and Medtronic withdraw pricey stents from Indian market
Recommended For You
About ABT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ABT | - | - |
Abbott Laboratories |